Fahimtar Nasara Kan Nau'ikan Halittar Manya B-DUKA

Janairu 15, 2025, Shanghai – Wani sharhi da aka buga kwanan nan a cikin mujallar Jini yana ba da cikakken bincike game da nau'ikan kwayoyin halitta na manyan ƙwayoyin B-cell na Lymphoblastic Leukemia (B-ALL), wata cuta mai saurin yaduwa da kuma mummunan sakamako tare da mummunan hasashen a cikin manya idan aka kwatanta da yara. A cikin shekaru ashirin da suka gabata, binciken kwayoyin halitta ya gano nau'ikan kwayoyin halitta daban-daban guda 20 na B-ALL, kowannensu yana da tasiri na musamman ga amsawar magani da kuma hasashen cutar.

Duk da cewa hanyoyin magance cututtukan da suka dace da haɗarin kwayoyin halitta sun kawo sauyi a dabarun magani a cikin yara B-ALL, yanayin kwayoyin halitta na manya B-ALL har yanzu ba a fahimce shi sosai ba. Wannan bita ya nuna mahimman bayanai game da bambancin halittu na nau'ikan kwayoyin halitta a cikin manya marasa lafiya kuma yana jaddada buƙatar haɗa bayanan kwayoyin halitta cikin binciken yau da kullun don ba da damar dabarun magani na musamman.

Muhimman Abubuwan da aka gano:

1. Filadelfia Chromosome-Positive (Ph+) B-ALL:
   Wakiltar nau'in da aka fi sani a cikin manya, musamman a cikin waɗanda suka haura shekaru 55, Ph+ B-ALL ya samo asali ne daga kwayar halittar haɗin BCR::ABL1. A tarihi, ana danganta shi da rashin kyakkyawan hasashen cutar, haɗakar masu hana tyrosine kinase (TKIs) da ƙwayoyin rigakafi na monoclonal da aka yi niyya, kamar blinatumomab, ya inganta yawan rayuwa sosai. Shaidun da ke fitowa sun nuna bambancin halittu masu yawa a cikin Ph+ B-ALL, yana nuna mahimmancin alamun kwayoyin halitta kamar IKZF1 don rarraba haɗari da tsara magani.

2. Sauye-sauyen Hypodiploidy da TP53:
   Ƙarancin sinadarin hypodiploidy, wanda ke da siffa ta chromosomes na 30-39, ya fi yawa a cikin manya kuma yana da alaƙa da mummunan sakamako. Binciken da aka yi kwanan nan ya nuna rawar da maye gurbi na TP53, wanda galibi yana da alaƙa da clonal hematopoiesis, ke takawa wajen haifar da wannan nau'in ciwon da ke da haɗari sosai. Binciken ya nuna cewa waɗannan maye gurbi ba wai kawai suna tasiri ga farkon cututtuka ba, har ma suna iya ba da gudummawa ga dabarun bayan an yi musu magani.

3. Sake tsara KMT2A:
   Sau da yawa ana ganin sake fasalin KMT2A a cikin manya B-ALL yana da alaƙa da mummunan sakamako. Sabbin hanyoyin magani, kamar masu hana menin, suna da alƙawarin magance juriyar magani na wannan nau'in.

4. Nau'ikan da ba a cika samu ba da kuma hanyoyin magance cututtuka masu tasowa:
   Nau'ikan da ke cikin wannan nau'in kamar haɗin TCF3::PBX1 da TCF3::HLF, duk da cewa ba kasafai ake samun su ba, suna nuna bambancin halittu da na asibiti. Bayanan da ke ƙarfafa gwiwa kafin a fara amfani da su sun nuna cewa suna da sauƙin kamuwa da sabbin magunguna kamar venetoclax da BET inhibitors, wanda hakan ke share fagen sabbin hanyoyin magani.

Tasirin Asibiti:

Binciken ya buƙaci a haɗa dabarun tantance kwayoyin halitta na zamani akai-akai, gami da jerin bayanai gaba ɗaya, don gano takamaiman nau'ikan kwayoyin halitta na manya B-ALL. Wannan hanyar za ta iya haɓaka rarrabuwar haɗari, jagorantar shawarwarin magani, da inganta sa ido kan ƙarancin cututtukan da suka rage (MRD).